MedPath

A Prospective Phase IV, cross over, single centre, investigator blinded study to evaluate the efficacy of Contractubex® Gel in the reduction and prevention of post surgery hypertrophic scar and keloid in subjects having undergone surgery by Sternotomy

Phase 4
Conditions
Health Condition 1: null- Males and females with recent (within 20 days) cardiac surgery.
Registration Number
CTRI/2012/12/003170
Lead Sponsor
MS Clinical Research Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
Not specified
Target Recruitment
80
Inclusion Criteria

Males and females with recent (within 20 days) cardiac surgery.

Age: 18 years or older

The subject willing and able to complete the entire course of the trial and comply with the trial instructions

Written informed consent

Exclusion Criteria

Any other planned topical treatment in the scar area

Any surgical wound discharge like purulent and serous at the time of initiation of therapy.

Tumorigenic changes in the area to treat, independent of tumor dignity

Any severe or uncontrolled systemic disease (e.g. pulmonary, hepatic, or gastrointestinal), malignant tumor, or medical history of HIV infection

Known allergy or sensitivity to the trial medication or its components.

Non compliant subjects

Psychiatric problems which, in the investigatorâ??s opinion, are severe enough to interfere with the trial results

Participation in another clinical trial within 30 days prior to screening

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the efficacy of Contractubex® Gel in reducing and preventing post surgery hypertrophic scar in immediate treatment (within 20 days post surgery) Vs no treatment for a period of six months.Timepoint: V1-Baseline (within 20days after surgery), V2-week 12, V3-week 24, V4 - week 36, V5-week 48
Secondary Outcome Measures
NameTimeMethod
To evaluate the efficacy of Contractubex® Gel in reducing post surgery scar in delayed treatment (starting of treatment six months post surgery) Vs no treatment (where subjects had prior treatment with Contractubex® gel for a period of six months).Timepoint: V1-Baseline (within 20days after surgery), V2-week 12, V3-week 24, V4 - week 36, V5-week 48
© Copyright 2025. All Rights Reserved by MedPath